NCT06283121
A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer treatment 2 not_yet_recruiting NCT06427252
The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM No drug interventions treatment 2 not_yet_recruiting NCT02976142
The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer No drug interventions treatment 2 unknown_status NCT01843725
Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers treatment 1 completed NCT06157892
A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors treatment 1 / 2 recruiting NCT06251973
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer treatment 2 recruiting NCT06264921
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06586957
A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04510064
PD-1 Antibody Combined With Modified FLOT Regimen in the Treatment of Unresectable Locally Advanced or Limited Metastatic Gastric Cancer treatment 2 unknown_status NCT04166721
WaKING: Wnt and checKpoint INhibition in Gastric Cancer treatment 1 / 2 active_not_recruiting NCT04739202
Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST) treatment 2 unknown_status NCT03751761
GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study treatment 1 / 2 completed NCT03121807
Home Parenteral Nutrition for Malnourished Unresectable Stage IV Gastric Cancer supportive_care Not Available completed NCT05143970
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors treatment 1 recruiting NCT02204306
Genotype Guided Chemotherapy in Gastric Cancer Patients No drug interventions treatment 2 completed NCT06250036
Peri-operative Zimberelimab (Anti-PD-1) vs Zimberelimab in Combination With Domvanalimab (Anti-TIGIT) in Resectable Mismatch Repair Deficient/Micro-satellite Unstable Gastric and Gastro-oesophageal Junctional Adenocarcinoma (ZODIAC) treatment 2 not_yet_recruiting NCT03614013
Resistance to Immunotherapy in Gastric Cancer No drug interventions Not Available Not Available unknown_status NCT05714124
Liver Embolization Approaches for Tumor Management No drug interventions Not Available Not Available recruiting NCT03698825
TEW-7197 With Paclitaxel for the Treatment of Metastatic Gastric Cancer treatment 1 / 2 unknown_status NCT06008925
Clinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric Cancer treatment 1 / 2 recruiting NCT05765357
Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers treatment 1 completed NCT02065765
International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer Not Available Not Available no_longer_available NCT01099527
A Trial of RAD001/Capecitabine in Refractory Gastric Cancer treatment 1 / 2 completed NCT02076594
Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer treatment 3 terminated NCT05940844
Study of OB-002 in Patients With Refractory Metastatic Cancer No drug interventions treatment 1 not_yet_recruiting NCT00632268
Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer treatment 2 completed NCT05024812
Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma treatment 1 / 2 recruiting NCT02310464
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects treatment 1 completed NCT05955833
89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study No drug interventions diagnostic 1 recruiting NCT04358354
Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer treatment 3 recruiting NCT05859477
Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer treatment 2 recruiting NCT01359397
Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer Not Available 2 unknown_status NCT03154983
The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer treatment 2 unknown_status NCT05230771
Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer No drug interventions treatment 3 not_yet_recruiting NCT02855788
Metronomic Chemotherapy in Advanced Gastric Cancer treatment 2 unknown_status NCT04618809
Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer No drug interventions health_services_research Not Available recruiting NCT06121700
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer treatment 2 recruiting NCT04263870
Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction treatment 2 unknown_status NCT00253370
Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer treatment 2 completed NCT03409848
Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma treatment 2 completed NCT05025826
Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy No drug interventions prevention Not Available recruiting NCT02668380
An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer No drug interventions Not Available Not Available unknown_status NCT01528501
Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008) treatment 2 terminated NCT02002195
Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer Not Available Not Available unknown_status NCT05703555
INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701 treatment 2 withdrawn NCT01814150
The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel No drug interventions Not Available Not Available unknown_status